Ruisheng Yang Selected Research

Ala-Thr-Trp-Leu-Pro-Pro-Arg

1/2015

The Neuropilin-1 Inhibitor, ATWLPPR Peptide, Prevents Experimental Diabetes-Induced Retinal Injury by Preserving Vascular Integrity and Decreasing Oxidative Stress.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ruisheng Yang Research Topics

Disease

2	Infections 01/2019 - 01/2015
1	Colorectal Neoplasms (Colorectal Cancer) 10/2021
1	Colonic Neoplasms (Colon Cancer) 10/2021
1	Neoplasms (Cancer) 10/2021
1	Ulcerative Colitis 10/2021
1	Ganglion Cysts (Ganglion) 07/2019
1	Wounds and Injuries (Trauma) 07/2017
1	Diarrhea 01/2016
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2015
1	Inflammation (Inflammations) 01/2015
1	Ischemia 01/2015
1	Reperfusion Injury 01/2015
1	Leukostasis 01/2015
1	Vascular System Injuries 01/2015

Drug/Important Bio-Agent (IBA)

4	Retinaldehyde (Retinal)IBA 07/2019 - 01/2015
2	Neuroprotective AgentsIBA 07/2017 - 01/2015
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 07/2017 - 01/2015
1	Butyric Acid (Butanoic Acid)IBA 10/2021
1	CyclodextrinsIBA 10/2021
1	Mesalamine (Mesalazine)FDA LinkGeneric 10/2021
1	Histone Deacetylase InhibitorsIBA 10/2021
1	Folic Acid (Vitamin M)FDA LinkGeneric 10/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 10/2021
1	LigandsIBA 10/2021
1	ProdrugsIBA 10/2021
1	ChitinIBA 01/2019
1	Capsaicin (Zostrix)FDA Link 07/2017
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2016
1	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2016
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2016
1	OccludinIBA 01/2015
1	AlbuminsIBA 01/2015
1	Peptides (Polypeptides)IBA 01/2015
1	Proteins (Proteins, Gene)FDA Link 01/2015
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2015
1	Carbapenems (Carbapenem Antibiotics)IBA 01/2015
1	Ala-Thr-Trp-Leu-Pro-Pro-ArgIBA 01/2015

Therapy/Procedure

1	Therapeutics 10/2021